Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer Patients

@article{Bge2008BevacizumabRelatedSS,
  title={Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer Patients},
  author={Thierry B{\`e}ge and Bernard Lelong and Fr{\'e}d{\'e}ric Viret and Olivier Turrini and J{\'e}r{\^o}me Guiramand and Delphine Topart and Laurence Moureau-Zabotto and Marc A Giovannini and Anthony Gonçalves and Jean Robert Delpero},
  journal={Annals of Surgical Oncology},
  year={2008},
  volume={16},
  pages={856-860}
}
Combining conventional systemic chemotherapy with the angiogenesis inhibitor bevacizumab is now recommended as a first treatment for metastatic colorectal neoplasms. The risk for short-term postoperative complications related to bevacizumab has been assessed. Late postoperative complications related to bevacizumab have also been suggested by preliminary reports. We reviewed a cohort of 142 patients with previous surgery for primary colonic or rectal tumor and without evidence of local… CONTINUE READING